… The pursuit of an imaging tool to visualize the protein alpha-synuclein, the hallmark … to accelerate this process through a concerted effort to combine resources and expertise from several different … Lewy bodies move through development, researchers could test whether they change levels of alpha-synuclein rather …

… (PD) vaccine called PD01, the first Parkinson’s drug to target alpha-synuclein to make it to the clinic. PD01 is … with expertise spanning the drug development pipeline come together with the shared goal of bringing new drugs to … do you unwind after work? MM: I’m lucky to live in Vienna, where we have such great access to outdoor sports at our …

… Cities Fox Trot , July 13  Then, we'll return to the cities where the Fox Trot 5K Series all began:   New York Fox Trot … October 13 Boston Fox Trot , October 20 Orlando Fox Trot , Coming soon! Registration is officially open; all ages and … full list of events to run, bike and compete with Team Fox, visit  teamfox.org/athletics . Kat McCarrick Associate …

… The Michael J. Fox Foundation (MJFF) announces 75 grants totaling more than $23 million awarded in June and July. … PDM608, which is a potential anti-inflammatory candidate to prevent cell loss. PDM608 is a long-acting version of a drug …   Parkinson’s Pathology & Assessing Progression  The most common practices to diagnose PD and to assess progression …

… UPDATE: The Economic Burden Survey is now available to the Parkinson's community . (Please do not participate in the survey again … expenses can be quantified, such as co-pays for doctor's visits and medications, but others are more difficult to …

… challenge spurring existing and new donors at every level to give, or increase giving, to The Michael J. Fox … to the LRRK2 field by MJFF-funded researchers and an unprecedented level of collaboration among all players,” said … Ms. Wojcicki is co-founder of 23andMe, a personal genetics company. About The Michael J. Fox Foundation for Parkinson’s …